New contributions to the drug profile of TNFα inhibitor SPD304: Affinity, selectivity and ADMET considerations
Aïda Mascret, Hadley Mouhsine, Ghada Attia, Damien Cabrera, Mohamed Benchekroun, Patrick Gizzi, Chouki Zerrouki, Najla Fourati, Jean‐François Zagury, Maité Sylla‐Iyarreta Veitía, Marc Port
Topics & Concepts
ChemistryTumor necrosis factor alphaIn silicoPharmacologyReceptorMechanism of actionCytotoxicityDrugIn vitroBiochemistryBiologyImmunologyGeneComputational Drug Discovery MethodsCytokine Signaling Pathways and InteractionsMonoclonal and Polyclonal Antibodies Research